TOFFOLI, GIUSEPPE
 Distribuzione geografica
Continente #
NA - Nord America 2.411
EU - Europa 1.883
AS - Asia 590
AF - Africa 27
SA - Sud America 15
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.935
Nazione #
US - Stati Uniti d'America 2.391
PL - Polonia 774
IT - Italia 404
SE - Svezia 254
CN - Cina 157
HK - Hong Kong 141
DE - Germania 77
SG - Singapore 73
BG - Bulgaria 55
UA - Ucraina 55
IN - India 50
GB - Regno Unito 45
IE - Irlanda 45
FI - Finlandia 39
TR - Turchia 32
VN - Vietnam 27
FR - Francia 26
PK - Pakistan 23
IR - Iran 21
BE - Belgio 20
JP - Giappone 20
SN - Senegal 17
CH - Svizzera 16
NL - Olanda 14
CA - Canada 13
ES - Italia 10
KR - Corea 10
BR - Brasile 9
RU - Federazione Russa 9
AU - Australia 8
ID - Indonesia 8
RO - Romania 8
DK - Danimarca 7
CZ - Repubblica Ceca 6
AT - Austria 5
CL - Cile 4
MY - Malesia 4
PH - Filippine 4
PR - Porto Rico 4
SA - Arabia Saudita 4
TH - Thailandia 4
AE - Emirati Arabi Uniti 3
HR - Croazia 3
MX - Messico 3
PT - Portogallo 3
RS - Serbia 3
ZA - Sudafrica 3
BD - Bangladesh 2
EG - Egitto 2
IQ - Iraq 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
CO - Colombia 1
CY - Cipro 1
EC - Ecuador 1
EE - Estonia 1
ET - Etiopia 1
GR - Grecia 1
HU - Ungheria 1
JO - Giordania 1
KE - Kenya 1
LA - Repubblica Popolare Democratica del Laos 1
MA - Marocco 1
MN - Mongolia 1
NO - Norvegia 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 4.935
Città #
Warsaw 772
Chandler 357
Fairfield 295
Ashburn 204
Woodbridge 200
Houston 159
Ann Arbor 146
Trieste 138
Seattle 137
Hong Kong 127
Wilmington 124
Cambridge 109
Princeton 76
Jacksonville 65
Sofia 55
Dublin 40
Redmond 37
Beijing 34
Singapore 30
Dearborn 28
Dong Ket 26
Izmir 25
Munich 24
Helsinki 21
Brussels 20
Rome 20
Boardman 19
Dakar 17
Shanghai 17
Los Angeles 14
London 13
Bern 12
Falls Church 12
Des Moines 10
Hefei 10
San Diego 10
Venezia 10
Boydton 9
Phoenix 9
Andover 8
Kunming 8
Lahore 8
Tokyo 8
Amsterdam 7
Columbus 7
Genoa 7
Nanjing 7
Seoul 7
Toronto 7
Washington 7
Atlanta 6
Deiva Marina 6
Milan 6
Zhengzhou 6
Bobigny 5
Brno 5
Central 5
Chennai 5
Kediri 5
Norwalk 5
Treviso 5
Turin 5
Vienna 5
Baton Rouge 4
Bayamón 4
Bielefeld 4
Bremen 4
Cincinnati 4
Denver 4
Fuzhou 4
Grafing 4
Guangzhou 4
Jequié 4
Nanchang 4
Reggio Emilia 4
Roorkee 4
Sydney 4
Almere Stad 3
Bangkok 3
Belgrade 3
Chongqing 3
Clifton 3
Coimbatore 3
Dallas 3
Delhi 3
Düsseldorf 3
Franklin Lakes 3
Gujranwala 3
Ivry-sur-seine 3
Jinan 3
Kocaeli 3
Kolkata 3
Magee 3
Mestre 3
Nepi 3
Norwich 3
Redwood City 3
Riyadh 3
San Francisco 3
Takaishi 3
Totale 3.706
Nome #
DNA Nanotechnology for Cancer Therapy 528
Polymer-mediated delivery of siRNAs to hepatocellular carcinoma: Variables affecting specificity and effectiveness 369
Androgen Receptor (AR) Gene (CAG)n and (GGN)n Length Polymorphisms and Symptoms in Young Males With Long-Lasting Adverse Effects After Finasteride Use Against Androgenic Alopecia 350
Azathioprine Biotransformation in Young Patients with Inflammatory Bowel Disease: Contribution of Glutathione-S Transferase M1 and A1 Variants 249
Bottom-up synthesis of carbon nanoparticles with higher doxorubicin efficacy 236
Exosomal doxorubicin reduces the cardiac toxicity of doxorubicin 225
Development and validation of LC-MS/MS method for imatinib and norimatinib monitoring by finger-prick DBS in gastrointestinal stromal tumor patients 192
A pharmacogenetic survey of androgen receptor (CAG)n and (GGN)n polymorphisms in patients experiencing long term side effects after finasteride discontinuation. 185
A new high-performance liquid chromatography-tandem mass spectrometry method for the determination of paclitaxel and 6α-hydroxy-paclitaxel in human plasma: Development, validation and application in a clinical pharmacokinetic study 179
A new high-performance liquid chromatography–tandem mass spectrometry method for the determination of sunitinib and N-desethyl sunitinib in human plasma: Light-induced isomerism overtaking towards therapeutic drug monitoring in clinical routine 167
Peptide biosensors for anticancer drugs: Design in silico to work in denaturizing environment 166
Label-Free Quantification of Anticancer Drug Imatinib in Human Plasma with Surface Enhanced Raman Spectroscopy 165
Cancer Pharmacogenetics: perspective on newly discovered and implemented predictive biomarkers 146
Surface-enhanced Raman spectroscopy of the anti-cancer drug irinotecan in presence of human serum albumin 137
Common mutations in immunoglobulin VK3 light chain sequences from B-cells of HCV-related disorders 129
Biocompatible tailored zirconia mesoporous nanoparticles with high surface area for theranostic applications 127
Exosomes increase the therapeutic index of doxorubicin in breast and ovarian cancer mouse models 126
Differential proteomic analysis of hepatocellular carcinoma 121
Association of the HLA-G 3'UTR polymorphisms with colorectal cancer in Italy: A first insight 106
Dried Blood Spot Technique Applied in Therapeutic Drug Monitoring of Anticancer Drugs: a Review on Conversion Methods to Correlate Plasma and Dried Blood Spot Concentrations 101
Analytical aspects of sunitinib and its geometric isomerism towards therapeutic drug monitoring in clinical routine 99
Soluble HLA-G expression levels and HLA-G/irinotecan association in metastatic colorectal cancer treated with irinotecan-based strategy 94
Machine Learning Application in a Phase I Clinical Trial Allows for the Identification of Clinical-Biomolecular Markers Significantly Associated With Toxicity 80
The Dual Role of the Liver in Nanomedicine as an Actor in the Elimination of Nanostructures or a Therapeutic Target 69
Simultaneous quantification of palbociclib, ribociclib and letrozole in human plasma by a new LC-MS/MS method for clinical application 67
A rapid, simple and sensitive LC-MS/MS method for lenvatinib quantification in human plasma for therapeutic drug monitoring 67
A New Epigenetic Model to Stratify Glioma Patients According to Their Immunosuppressive State 62
A new dried blood spot LC-MS/MS method for therapeutic drug monitoring of palbociclib, ribociclib, and letrozole in patients with cancer 62
Nanoparticles-based oligonucleotides delivery in cancer: Role of zebrafish as animal model 61
Development and validation of a selective SPR aptasensor for the detection of anticancer drug irinotecan in human plasma samples 56
A novel epigenetic machine learning model to define risk of progression for hepatocellular carcinoma patients 54
Glucose Metabolism and Oxidative Stress in Hepatocellular Carcinoma: Role and Possible Implications in Novel Therapeutic Strategies 54
New insight into therapies targeting angiogenesis in hepatocellular carcinoma 53
Identification of Novel Somatic TP53 Mutations in Patients with High-Grade Serous Ovarian Cancer (HGSOC) Using Next-Generation Sequencing (NGS) 47
A LC–MS/MS method for therapeutic drug monitoring of sorafenib, regorafenib and their active metabolites in patients with hepatocellular carcinoma 47
An SPR investigation into the therapeutic drug monitoring of the anticancer drug imatinib with selective aptamers operating in human plasma 47
Biological Features of Nanoparticles: Protein Corona Formation and Interaction with the Immune System 44
Predictive role of microRNA-related genetic polymorphisms in the pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients 43
Pharmacogenetics Biomarkers and Their Specific Role in Neoadjuvant Chemoradiotherapy Treatments: An Exploratory Study on Rectal Cancer Patients 42
Nanocarriers as a Delivery Platform for Anticancer Treatment: Biological Limits and Perspectives in B-Cell Malignancies 28
Totale 5.180
Categoria #
all - tutte 14.140
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.140


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020992 0 70 51 157 99 128 119 81 93 52 67 75
2020/2021734 67 51 94 64 88 58 70 40 43 62 25 72
2021/2022605 21 20 41 21 9 96 41 12 68 47 29 200
2022/20231.230 94 160 110 151 98 172 48 116 137 60 57 27
2023/2024647 38 35 36 56 45 67 102 151 7 19 60 31
2024/202546 39 7 0 0 0 0 0 0 0 0 0 0
Totale 5.180